{"disease":{"id":"xeroderma-pigmentosum","name":"xeroderma pigmentosum"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00001813","title":"Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy","phase":"","overall_status":"COMPLETED","enrollment_count":709,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06330324","title":"Reproductive Options in Inherited Skin Diseases","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":650,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT00046189","title":"Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum","phase":"","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05484570","title":"Natural History Study for DNA Repair Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT03445052","title":"XPAND Trial: Enhancing XP Photoprotection Activities - New Directions","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT04500548","title":"Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}